Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB) (click to learn more) AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News INmune Bio Inc INMB

Healthcare Biotechnology
INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company’s development programs include INKmune, which is in Phase 1 for the treatment of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:INMB)

INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives

GlobeNewswire 13 days ago

Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio's CORDStrom(TM) Platform

GlobeNewswire December 5, 2025

INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595's Evidence Base in High-Inflammation Alzheimer's Patients

GlobeNewswire December 1, 2025

INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference

GlobeNewswire November 18, 2025

INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update

GlobeNewswire October 30, 2025

INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025

GlobeNewswire October 23, 2025

INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025

GlobeNewswire October 14, 2025

INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer's Disease to npj Dementia, a Nature Portfolio Journal

GlobeNewswire September 29, 2025

INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom(TM) at CGT Catapult

GlobeNewswire September 15, 2025
View More News ››

Opinion & Analysis (NDAQ:INMB)

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

Streetwise Reports December 5, 2019
View More Opinion ››

Bullboard Posts (NDAQ:INMB)

Buy buddy buy because it's taking off this morning.

Otherwise FOMO
coolfooldumbguy - June 27, 2025

INMB XPro™ Promotes Remyelination

https://us15.campaign-archive.com/?e=1c52cd69f7&u=4a549c7aea3073da1e942d0ce&id=9f6b228d23
zardoz00 - October 24, 2024

INMB completes phase two enrollment

https://us15.campaign-archive.com/?e=1c52cd69f7&u=4a549c7aea3073da1e942d0ce&id=5cb6aa3bde
zardoz00 - September 30, 2024

INMB Provides Update on Two Patients from the P1A with AD

Very good news! https://mail.google.com/mail/u/0/#inbox/FMfcgzGxStxShvDQGLmpNvjKCBszgRhR
zardoz00 - April 30, 2024

RE:RE:RE:When the Price of (INMB) Talks, People Listen

Can e reach the market of ibrx? Maybe not this year, but certainly possible 2-3 years out.
Teccing - April 29, 2024

RE:RE:When the Price of (INMB) Talks, People Listen

 More encouraging new, with multiple fronts it's going to be a busy year.
Teccing - April 29, 2024
View more Bullboard ››

Virtuix Holdings Inc

Virtuix Holdings Inc

View More »

Podcasts